Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metformin Inhibits the Type 1 IFN Response in Human CD4+ T Cells
Anton A. Titov, Henry V. Baker, Todd M. Brusko, et al.
The Journal of Immunology (2019) Vol. 203, Iss. 2, pp. 338-348
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Metformin: update on mechanisms of action and repurposing potential
Marc Foretz, Bruno Guigas, Benoı̂t Viollet
Nature Reviews Endocrinology (2023) Vol. 19, Iss. 8, pp. 460-476
Open Access | Times Cited: 339
Metformin attenuated sepsis-related liver injury by modulating gut microbiota
Huoyan Liang, Heng Song, Xiaojuan Zhang, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 815-828
Open Access | Times Cited: 122
Systemic Lupus Erythematosus Pathogenesis: Interferon and Beyond
Simone Caielli, Zurong Wan, Virginia Pascual
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 533-560
Open Access | Times Cited: 108
Metformin as an anti-inflammatory agent: a short review
Robin Kristófi, Jan W. Eriksson
Journal of Endocrinology (2021) Vol. 251, Iss. 2, pp. R11-R22
Open Access | Times Cited: 82
Mitochondrial Metabolism Regulation of T Cell–Mediated Immunity
Elizabeth M. Steinert, Karthik Vasan, Navdeep S. Chandel
Annual Review of Immunology (2021) Vol. 39, Iss. 1, pp. 395-416
Open Access | Times Cited: 63
Metformin and Its Immune-Mediated Effects in Various Diseases
Ichiro Nojima, Jun Wada
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 1, pp. 755-755
Open Access | Times Cited: 27
Metformin to decrease COVID-19 severity and mortality: Molecular mechanisms and therapeutic potential
Oleksandr Kamyshnyi, V. M. Matskevych, Tetyana Lenchuk, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 144, pp. 112230-112230
Open Access | Times Cited: 55
The AMP-Activated Protein Kinase Plays a Role in Antioxidant Defense and Regulation of Vascular Inflammation
Thomas Jansen, Miroslava Kvandová, Andreas Daiber, et al.
Antioxidants (2020) Vol. 9, Iss. 6, pp. 525-525
Open Access | Times Cited: 51
Loss of Gut Barrier Integrity In Lupus
Longhuan Ma, Laurence Morel
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 38
Remodeling of T-cell mitochondrial metabolism to treat autoimmune diseases
Liyan Lin, Ruyu Ren, Qiao Xiong, et al.
Autoimmunity Reviews (2024) Vol. 23, Iss. 6, pp. 103583-103583
Open Access | Times Cited: 6
Regulation and inhibition of the DNA sensor cGAS
Jonny Hertzog, Jan Rehwinkel
EMBO Reports (2020) Vol. 21, Iss. 12
Open Access | Times Cited: 50
Safety and efficacy of metformin in systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled trial
Fangfang Sun, Hui Jing Wang, Zhe Liu, et al.
The Lancet Rheumatology (2020) Vol. 2, Iss. 4, pp. e210-e216
Closed Access | Times Cited: 49
Advances in systemic lupus erythematosus pathogenesis via mTOR signaling pathway
Jingjing He, Jun Ma, Bingrui Ren, et al.
Seminars in Arthritis and Rheumatism (2019) Vol. 50, Iss. 2, pp. 314-320
Open Access | Times Cited: 48
Metformin as a Potential Agent in the Treatment of Multiple Sclerosis
Angela Dziedzic, Joanna Saluk, Elżbieta Miller, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 5957-5957
Open Access | Times Cited: 48
Metabolic determinants of lupus pathogenesis
Xiangyu Teng, Josephine Brown, Seung‐Chul Choi, et al.
Immunological Reviews (2020) Vol. 295, Iss. 1, pp. 167-186
Open Access | Times Cited: 46
Metformin and its therapeutic applications in autoimmune inflammatory rheumatic disease
JW Kim, Jung‐Yoon Choe, Sung‐Hwan Park
The Korean Journal of Internal Medicine (2021) Vol. 37, Iss. 1, pp. 13-26
Open Access | Times Cited: 36
Adverse Effects of Metformin From Diabetes to COVID-19, Cancer, Neurodegenerative Diseases, and Aging: Is VDAC1 a Common Target?
Varda Shoshan‐Barmatz, Uttpal Anand, Edna Nahon-Crystal, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 34
Mitochondrial bioenergetic changes in systemic lupus erythematosus immune cell subsets: Contributions to pathogenesis and clinical applications
Anjali Yennemadi, Joseph Keane, Gina Leisching
Lupus (2023) Vol. 32, Iss. 5, pp. 603-611
Open Access | Times Cited: 11
Abnormal energy metabolism in the pathogenesis of systemic lupus erythematosus
Shumei Cao, Jiao Jiang, Haoyuan Yin, et al.
International Immunopharmacology (2024) Vol. 134, pp. 112149-112149
Closed Access | Times Cited: 4
Alpha-1 Antitrypsin Overexpressing Mesenchymal Stem/Stromal Cells Reverses Type 1 Diabetes via Promoting Treg Function and CD8+T cell exhaustion
Hua Wei, Wenyu Gou, Judong Kim, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Metabolic regulation of pathogenic autoimmunity: therapeutic targeting
Xiangyu Teng, Caleb Cornaby, Wei Li, et al.
Current Opinion in Immunology (2019) Vol. 61, pp. 10-16
Open Access | Times Cited: 34
T cell Metabolism in Lupus
Milena Vukelic, Michihito Kono, George C. Tsokos
Immunometabolism (2020) Vol. 2, Iss. 2
Open Access | Times Cited: 31
Immune–Metabolic Interactions and T Cell Tolerance in Pregnancy
Lachlan M. Moldenhauer, M. Louise Hull, Kerrie L. Foyle, et al.
The Journal of Immunology (2022) Vol. 209, Iss. 8, pp. 1426-1436
Open Access | Times Cited: 18
Metformin ameliorates chronic colitis in a mouse model by regulating interferon‐γ‐producing lamina propria CD4 + T cells through AMPK activation
Masahiro Takahara, Akinobu Takaki, Sakiko Hiraoka, et al.
The FASEB Journal (2022) Vol. 36, Iss. 2
Closed Access | Times Cited: 17
Metformin as a therapeutic agent for obesity-associated immune dysfunction
Devika Rajeev, Nancie J. MacIver
Journal of Nutrition (2024) Vol. 154, Iss. 8, pp. 2534-2542
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top